Dano, Melitona D.

HRN: 15-69-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2024
CEFUROXIME 1.5GM (VIAL)
02/23/2024
03/01/2024
IV
750 Mg
Every 8 Hours
S/P Parotidectomy, Left

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Non-compliant To Guidelines